What is the role of alternative biomarkers for coronary heart disease?
- PMID: 21521314
- DOI: 10.1111/j.1365-2265.2011.04045.x
What is the role of alternative biomarkers for coronary heart disease?
Abstract
Predictive models for future risk of coronary heart disease (CHD) based on traditional risk factors, such as age, male gender, LDL cholesterol, HDL cholesterol, diabetes mellitus, hypertension, smoking and family history of premature CHD, are quite robust but leave room for further improvement. Thus, efforts are being made to assess additional biomarkers for CHD, such as, lipoprotein (a), C-reactive protein, fibrinogen, lipoprotein-associated phospholipase A2, homocysteine and others. However, none of the novel biomarkers has demonstrated improved prediction beyond traditional risk factor models in a consistent fashion across multiple cohorts. Many criteria have to be fulfilled before a biomarker can be considered clinically relevant. Another way is to develop new models predicting long-term or life-time risk of CHD. Further research using novel biomarkers and long-term predictive models has the potential to improve CHD risk prediction.
© 2011 Blackwell Publishing Ltd.
Similar articles
-
Predictors of coronary heart disease events among asymptomatic persons with low low-density lipoprotein cholesterol MESA (Multi-Ethnic Study of Atherosclerosis).J Am Coll Cardiol. 2011 Jul 19;58(4):364-74. doi: 10.1016/j.jacc.2011.01.055. J Am Coll Cardiol. 2011. PMID: 21757113
-
Biomarkers for predicting postmenopausal coronary heart disease.Biomark Med. 2011 Aug;5(4):485-95. doi: 10.2217/bmm.11.51. Biomark Med. 2011. PMID: 21861670 Review.
-
Are novel serum biomarkers informative?Med Clin North Am. 2012 Jan;96(1):1-11. doi: 10.1016/j.mcna.2012.01.017. Med Clin North Am. 2012. PMID: 22391247 Review.
-
Inflammatory markers in coronary heart disease.Br Med Bull. 2011;100:23-38. doi: 10.1093/bmb/ldr043. Epub 2011 Oct 18. Br Med Bull. 2011. PMID: 22010105 Review.
-
Lipoprotein-associated phospholipase A2: an independent predictor of coronary artery disease events in primary and secondary prevention.Am J Cardiol. 2008 Jun 16;101(12A):23F-33F. doi: 10.1016/j.amjcard.2008.04.015. Am J Cardiol. 2008. PMID: 18549868 Review.
Cited by
-
Metabolic biomarkers for predicting cardiovascular disease.Vasc Health Risk Manag. 2013;9:37-45. doi: 10.2147/VHRM.S30378. Epub 2013 Jan 29. Vasc Health Risk Manag. 2013. PMID: 23386789 Free PMC article. Review.
-
Effectiveness of cognitive behavioral therapy-based interventions on health outcomes in patients with coronary heart disease: A meta-analysis.World J Psychiatry. 2021 Nov 19;11(11):1147-1166. doi: 10.5498/wjp.v11.i11.1147. eCollection 2021 Nov 19. World J Psychiatry. 2021. PMID: 34888180 Free PMC article.
-
Premature coronary heart disease and autosomal dominant hypercholesterolemia: Increased risk in women with LDLR mutations.J Clin Lipidol. 2016 Jan-Feb;10(1):101-8.e1-3. doi: 10.1016/j.jacl.2015.09.003. Epub 2015 Sep 25. J Clin Lipidol. 2016. PMID: 26892126 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials